H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral

Intercept Announces Departure of Chief Financial Officer

March 10, 2021 8:00 AM EST

Rocco Venezia Appointed Chief Accounting Officer and Acting CFO -Intercept Reiterates 2021 Financial Guidance -

NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Sandip Kapadia, Chief Financial Officer, will leave Intercept to pursue another opportunity. Mr. Kapadia will continue to serve as Chief Financial Officer until his departure on March 26, 2021. The Company also announced Mr. Rocco Venezia will be appointed Chief Accounting Officer and... More